Development of 1st-in-class personalized organometallic with a unique &a; innovative mode of action coupled with nanoparticle
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Boulogne-billancourt
State: Ile-de-France
Zip:
Country: France
Feroscan was set up in 2014 at the initiative of its four founders bringing together scientific and business skills. Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian, triple negative breast and NSCL cancers. Feroscan’s business strategy is to test in parallel several preclinical programs on several orphan applications up to proof of concept, IND and early clinical stages. Feroscan is based on a strong IP strategy, cutting edge science and relies on a strong academic and industrial network worldwide to develop clinical applications of its research programs.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2015 | Debt Financing | 1 | $66k |
Wilco Wilco |
5/2019 | Debt Financing | 1 | $112k |
Bpifrance Bpifrance |
7/2018 | Seed Round | 1 | $412.9k |
Groupe Azeden Groupe Azeden |
7/2019 | Grant | $0 |
Agence National de la Recherche Agence National de la Recherche |
7/2019 | Grant | 1 | $11.3k |
Aviva Group Aviva Group |
6/2015 | Grant | 1 | $131.1k |
Paris Sciences et Lettres Paris Sciences et Lettres |
7/2019 | Grant | 1 | $540k |
Agence National de la Recherche Agence National de la Recherche |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|